# Prognostic Value of KELIM Score and Inflammatory Markers in Ovarian Cancer

> **NCT07678008** · — · ACTIVE_NOT_RECRUITING · sponsor: **Aya Ahmed Nasser** · enrollment: 80 (estimated)

## Conditions studied

- Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
- High-grade Serous Ovarian Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07678008
- **Lead sponsor:** Aya Ahmed Nasser
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07678008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07678008, "Prognostic Value of KELIM Score and Inflammatory Markers in Ovarian Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07678008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*